Detection of Circulating Tumor DNA in Early- and Late-Stage Human MalignanciesChetan Bettegowda, Jon Weingart, Mark Sausen et al.|Science Translational Medicine|2014Cited by 5.1k
Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trialGerald S. Falchook, Leslie A. Fecher, Ngocdiep T. Le et al.|The Lancet Oncology|2012Cited by 541
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer ConsortiumPetros Grivas, Shuchi Gulati, Ali Raza Khaki et al.|Annals of Oncology|2021Cited by 326
Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort StudyDonna R. Rivera, Jeremy L. Warner, Solange Peters et al.|Cancer Discovery|2020Cited by 138
Biomarker Trends, Incidence, and Outcomes of Immune Checkpoint Inhibitor–Induced MyocarditisAlexi Vasbinder, Salim S. Hayek, YeeAnn Chen et al.|JACC CardioOncology|2022Cited by 78